Որոնման արդյունքները - C. Michael Gibson
- Ցուցադրվում են 1 - 20 արդյունքները 162
- Գնացեք Հաջորդ էջ
-
1
Coronary and Myocardial Angiography C. Michael Gibson, Albert Schömig
Հրապարակվել է 2004Revisão -
2
-
3
-
4
-
5
Association Between White Blood Cell Count, Epicardial Blood Flow, Myocardial Perfusion, and Clinical Outcomes in the Setting of Acute Myocardial Infarction Hal V. Barron, Christopher P. Cannon, Sabina A. Murphy, Eugene Braunwald, C. Michael Gibson
Հրապարակվել է 2000Artigo -
6
-
7
-
8
-
9
Six-month angiographic and clinical follow-up of patients prospectively randomized to receive either tirofiban or placebo during angioplasty in the RESTORE trial C. Michael Gibson, Mukesh Goel, David J. Cohen, Robert N. Piana, Lawrence I. Deckelbaum, K HARRIS, Spencer B. King
Հրապարակվել է 1998Artigo -
10
Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trial Gerald Chi, C. Michael Gibson, Yuyin Liu, Adrian F. Hernandez, Russell D. Hull, Alexander T. Cohen, Robert A. Harrington, Samuel Z. Goldhaber
Հրապարակվել է 2018Artigo -
11
Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary Syndromes Marc S. Sabatine, David A. Morrow, Robert P. Giugliano, Paul Burton, Sabina A. Murphy, Carolyn H. McCabe, C. Michael Gibson, Eugene Braunwald
Հրապարակվել է 2005Artigo -
12
-
13
-
14
Worldwide differences of hospitalization for ST-segment elevation myocardial infarction during COVID-19: A systematic review and meta-analysis Francesco Sofi, Monica Dinu, Gianpaolo Reboldi, Fabrizio Stracci, Roberto F.E. Pedretti, Serafina Valente, GianFranco Gensini, C. Michael Gibson, Giuseppe Ambrosio
Հրապարակվել է 2021Revisão -
15
The design and rationale for the Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban (APEX) study Alexander T Cohen, Robert A. Harrington, Samuel Z. Goldhaber, Russell D. Hull, C. Michael Gibson, Adrian F. Hernandez, Michael M. Kitt, Todd J. Lorenz
Հրապարակվել է 2013Artigo -
16
Benefit of Transferring ST-Segment–Elevation Myocardial Infarction Patients for Percutaneous Coronary Intervention Compared With Administration of Onsite Fibrinolytic Declines as D... Duane S. Pinto, Frederick A. Spencer, Anjan Chakrabarti, Ajay J. Kirtane, Edward Ullman, Andrè Dejam, Dave P. Miller, Timothy D. Henry, C. Michael Gibson
Հրապարակվել է 2011Artigo -
17
Angiographic and Clinical Outcomes Among Patients With Acute Coronary Syndromes Presenting With Isolated Anterior ST-Segment Depression Yuri B. Pride, Patricia Tung, Satishkumar Mohanavelu, Cafer Zorkun, Stephen D. Wiviott, Elliott M. Antman, Robert P. Giugliano, Eugene Braunwald, C. Michael Gibson
Հրապարակվել է 2010Artigo -
18
Factors associated with early, late, and very late stent thrombosis among patients with acute coronary syndrome undergoing coronary stent placement: analysis from the ATLAS ACS 2-T... Gerald Chi, Fahad Alkhalfan, Jane Lee, Sahar Memar Montazerin, Clara Fitzgerald, Serge Korjian, Wally Omar, Elliot S. Barnathan, Alexei N. Plotnikov, C. Michael Gibson
Հրապարակվել է 2024Artigo -
19
-
20
Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the thrombolysis in myocardial infarction trials C. Michael Gibson, Juhana Karha, Sabina A. Murphy, David James, David A. Morrow, Christopher P. Cannon, Robert P. Giugliano, Elliott M. Antman, Eugene Braunwald
Հրապարակվել է 2003Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Medicine
Internal medicine
Cardiology
Myocardial infarction
Percutaneous coronary intervention
Surgery
Confidence interval
Acute coronary syndrome
Randomized controlled trial
TIMI
Conventional PCI
Heart failure
Hazard ratio
Pathology
Clinical endpoint
Atrial fibrillation
Intensive care medicine
Thrombolysis
Coronary artery disease
Clopidogrel
Alternative medicine
Placebo
Aspirin
Adverse effect
Anesthesia
Warfarin
Odds ratio
Antithrombotic
Engineering
Environmental health